一个心力衰竭智能手机应用程序,它将患者/医生推向最佳医疗疗 - - 开发和可用性研究
Kosuke Hayashi1, Kenta Hachiya2, Keisuke Yonezu3
1Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine, Oita University Yufu Japan.
Circulation reports
|December 11, 2023
概括
使用行为经济学的新智能手机应用程序显示,它有望改善心力衰竭 (HF) 治疗坚持. 对HF患者的早期可用性测试产生了出色的结果,这表明更大的疗效研究的可行性.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 行为经济学是一种行为经济学.
背景情况:
- 针对心力衰竭 (HF) 的指南导向医学疗法 (GDMT) 在全球范围内实施率较低.
- 优化医疗治疗对于改善心力衰竭患者的结果至关重要.
研究的目的:
- 开发和评估智能手机应用程序的可用性,旨在改善医生和患者对心力衰竭的GDMT的坚持.
- 探索一种可扩展的,基于行为经济学的方法,以提高HF治疗的实施.
主要方法:
- 开发了一种采用行为经济学原理的原型智能手机应用程序.
- 使用性测试是在门诊环境中对5名心力衰竭患者的小队列进行的.
主要成果:
- 开发的智能手机应用程序在参与的患者中表现出了出色的坚持.
- 患者报告了应用程序的高可用性评级.
结论:
- 一个利用行为经济学的智能手机应用程序似乎是一个可行的和潜在的可扩展的工具,用于改善心力衰竭的指导方针导向医学治疗.
- 需要在更大的队列中进行进一步的研究,以评估这项数字健康干预措施对心力衰竭管理的有效性.
相关概念视频
Pulse rhythm
807
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
807
Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436


